insiderwall
Menu
SuperinvestorInsider
Luminex Corp. LMNX

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Luminex Corp. is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. The company's core technology platform, xMAP, enables simultaneous analysis of multiple bioassays from minimal …

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Instruments & Supplies
CountryUnited States
Employees1,325
TickerLMNX

Statistics

Market Cap$633.3M
Revenue (TTM)—
Net Income—
Net Margin—
EPS—
P/E73.83
P/S—
P/B—
EV/EBITDA—
ROE—
Dividend Yield—
Price$13.39

Data: Twelve Data · Revenue = mcap / P/S

Luminex Corp. (LMNX) — Azioni, fondamentali e superinvestor | InsiderWall